Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

traZODone

traZODone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Oleptro TABLET, EXTENDED RELEASE, ORAL 150 mg, 300 mg    
Desyrel TABLET, ORAL 50 mg, 100 mg, 150 mg      
VIEW MORE Selective-serotonin Reuptake Inhibitors, Serotonin Modulators
CLASS
28160420, 28160424
Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

traZODone (Oleptro)

  • 150 mg extended release tablet daily
  • ONE 150 mg extended release tablet PLUS HALF 150 mg extended release tablet daily (Total: 175 mg)
  • 300 mg extended release tablet daily
  • ONE 300 mg extended release tablet PLUS one 150 mg extended release PLUS HALF 150 mg extended release tablet (Total: 375 mg)

traZODone (Desyrel)

  • 50 mg tablet q 8 hours              
  • 50 mg tablet q 6 hours                                                                                                                                                                        
  • 100 mg tablet q 8 hours
  • 100 mg tablet q 6 hours

Desyrel medication guide

Oleptro medication guide

traZODone medication guide

Reviewed: September 28, 2010 (OLEPTRO)

Last updated: Aug. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved